GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, EPIDIOLEX (cannabidiol) oral solution, is commercialized in the U.S. by its U.S. subsidiary Greenwich Biosciences for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients one year of age and older. This product has received approval in the European Union under the tradename EPIDYOLEX for the adjunctive treatment of seizures associated with LGS or Dravet syndrome in conjunction with clobazam in patients two years and older and is under EMA review for the treatment of TSC. The Company has a deep pipeline of additional cannabinoid product candidates, in particular nabiximols, for which the Company is advancing multiple late-stage clinical programs in order to seek FDA approval in the treatment of spasticity associated with multiple sclerosis and spinal cord injury. The Company has additional cannabinoid product candidates in clinical trials for autism and schizophrenia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of GW Pharmaceuticals - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. GW Pharmaceuticals - ADR market cap is $6.9B.
What is the 52-week high for GW Pharmaceuticals - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. GW Pharmaceuticals - ADR 52 week high is $219.57 as of September 08, 2025.
What is the 52-week low for GW Pharmaceuticals - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. GW Pharmaceuticals - ADR 52 week low is $87.07 as of September 08, 2025.
What is GW Pharmaceuticals - ADR stock price today?
GW Pharmaceuticals - ADR stock price today is $219.16.
What was GW Pharmaceuticals - ADR stock price yesterday?
GW Pharmaceuticals - ADR stock price yesterday was $219.28.
What is the PE ratio of GW Pharmaceuticals - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. GW Pharmaceuticals - ADR’s P/E ratio is -97.55.
What is the Price-to-Book ratio of GW Pharmaceuticals - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. GW Pharmaceuticals - ADR P/B ratio is 9.3790.
What is the 50-day moving average of GW Pharmaceuticals - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. GW Pharmaceuticals - ADR 50-day moving average is $216.92.